European-wide MRD screening should be available for all
How has MRD changed our ability to diagnose leukemia?
Future of aggressive lymphoma treatment: a shift towards chemo-free regimens
Results of the COG AALL0434 trial for T-cell malignancies
The ALL frontier: should T-ALL be classed as a different disease?